title: [Herpes zoster in old adults].
abstract: The varicella-zoster virus is an exclusively human herpesvirus, responsible for chickenpox. Its reactivation, after several decades, causes herpes zoster (shingles). Herpes zoster produces a rash, classically metameric, that causes acute pain and complications to elderly patients. The last, most painful, and disabling of these is postherpetic neuralgia. This neuralgia is defined as a painful syndrome lasting for more than 30 days after eruption of the rash. Today's systemic antiviral drugs can reduce the severity of the eruption, limit the pain, and diminish the incidence of postherpetic neuralgia. A recent advance in primary prevention is approval of a vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia in subjects 60 years or older.
authors.affiliation: Département de réhabilitation et gériatrie, Faculté de médecine et Hôpitaux universitaires de Genève, CH-1226 Thônex-Genève, Suisse. Pierre.O.Lang@hcuge.ch
authors.forename: Pierre-Olivier
authors.initials: PO
authors.lastname: Lang
authors.forename: Joël
authors.initials: J
authors.lastname: Belmin
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Michel
mesh_terms: D000368:Aged; D000700:Analgesics / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D006562:Herpes Zoster / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D053061:Herpes Zoster Vaccine / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D051474:Neuralgia, Postherpetic / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D012307:Risk Factors; D014775:Virus Activation
chemical_list: D000700:Analgesics; D000998:Antiviral Agents; D053061:Herpes Zoster Vaccine